These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 225888)
1. [Levels of humoral antibodies to Epstein-Barr virus in the population of Cuba]. Le Riverand Morales E; Gurtsevich VE; Ruíz García R Vopr Virusol; 1979; (4):399-405. PubMed ID: 225888 [TBL] [Abstract][Full Text] [Related]
2. Sero-epidemiologic study of the Epstein--Barr virus infectivity in a healthy Cuban population. Gurtsevich V; Le Riverend E; Ruíz R Neoplasma; 1979; 26(6):677-83. PubMed ID: 232252 [TBL] [Abstract][Full Text] [Related]
3. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba]. Gurtsevich VE; Ruíz García R; Cuevas J; Le Riverand Morales E; Ascue M Vopr Virusol; 1979; (4):392-9. PubMed ID: 225887 [TBL] [Abstract][Full Text] [Related]
4. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity. Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343 [TBL] [Abstract][Full Text] [Related]
5. Elevated IgA antibodies to Epstein-Barr virus in children with chronic active Epstein-Barr virus infection. Wakiguchi H; Fujieda M; Kubota H; Matsumoto K; Wakiguchi A; Kurashige T; Oda M Acta Med Okayama; 1989 Jun; 43(3):193-6. PubMed ID: 2548373 [TBL] [Abstract][Full Text] [Related]
6. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba. Ruiz R; Gurtsevich V; Le Riverend E Neoplasma; 1979; 26(2):125-31. PubMed ID: 224330 [TBL] [Abstract][Full Text] [Related]
7. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit]. Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576 [TBL] [Abstract][Full Text] [Related]
8. Antibody response to Epstein-Barr virus antigens in patients with chronic viral infection. Roubalová K; Roubal J; Skopový P; Fucíková T; Domorázková E; Vonka V J Med Virol; 1988 May; 25(1):115-22. PubMed ID: 2842443 [TBL] [Abstract][Full Text] [Related]
9. Contribution to rapid diagnosis of infectious mononucleosis. Franková V; Stanková M; Kouba K; Hásková V; Pavlík E Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728 [TBL] [Abstract][Full Text] [Related]
10. Serological follow-up of children with infectious mononucleosis caused by Epstein-Barr virus. Timár L; Koller M; Budai J Acta Paediatr Acad Sci Hung; 1981; 22(3):243-9. PubMed ID: 6272540 [TBL] [Abstract][Full Text] [Related]
11. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)]. Seigneurin JM; Kressmann MC; Lavoué MF; Saez G; Lenoir G Nouv Presse Med; 1978 Dec; 7(44):4005-10. PubMed ID: 215969 [TBL] [Abstract][Full Text] [Related]
12. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138 [TBL] [Abstract][Full Text] [Related]
13. The significance of serum IgM IgA and IgG antibodies specific for Epstein-Barr virus as determined by immunoperoxidase assay in the rapid diagnosis of infectious mononucleosis. Hadar T; Margalith M; Sagiv E; Sarov B; Sarov I Isr J Med Sci; 1995 May; 31(5):280-3. PubMed ID: 7759222 [TBL] [Abstract][Full Text] [Related]
15. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. Joncas J; Monczak Y; Ghibu F; Alfieri C; Bonin A; Ahronheim G; Rivard G J Med Virol; 1989 Jun; 28(2):110-7. PubMed ID: 2544675 [TBL] [Abstract][Full Text] [Related]
16. Seroepidemiological study of Epstein-Barr virus infection in Bangladesh. Haque T; Iliadou P; Hossain A; Crawford DH J Med Virol; 1996 Jan; 48(1):17-21. PubMed ID: 8825705 [TBL] [Abstract][Full Text] [Related]
17. The serological signs of the Epstein-Barr virus (EBV) activity in the elderly. Ternák G; Szúcs G; Uj M Acta Microbiol Immunol Hung; 1997; 44(2):133-40. PubMed ID: 9330661 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups. Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990 [TBL] [Abstract][Full Text] [Related]
19. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis. Touge C; Agawa H; Sairenji T; Inoue Y Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases. Joncas JH; Wills A; Reece E; Fox Z Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]